Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2095157 Target Snapshot

Cyclooxygenase · PROTEIN FAMILY · Rattus norvegicus

757Compounds
112Assays
9Approved Drugs
583.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P35355. Use UniProt P35355 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P35355 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cyclooxygenase as ChEMBL target CHEMBL2095157, mapped to UniProt P35355. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cyclooxygenase
PROTEIN FAMILY · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL2095157
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P35355
Prostaglandin G/H synthase 2
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cyclooxygenase is the right protein anchor across sources, using UniProt P35355 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelProstaglandin G/H synthase 2
UniProt AccessionP35355
Component TypeProtein
Sequence Length604 aa

Prostaglandin G/H synthase 2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cyclooxygenase, mapped to UniProt P35355. ChEMBL maps the protein component as Prostaglandin G/H synthase 2. Sequence length is 604 aa.

Mapped IDP35355
Review nameCyclooxygenase
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

9
Approved
1
Phase III
9
Phase II
Assay Mix

Activity Type Distribution

IC50583.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL305076 8.68 IC50 2.1 Preclinical
CHEMBL60496 8.6 IC50 2.5 Preclinical
CHEMBL64507 8.6 IC50 2.5 Preclinical
CHEMBL6 8.54 IC50 2.9 Approved
CHEMBL341135 8.4 IC50 4.0 Preclinical
CHEMBL126669 8.38 IC50 4.2 Preclinical
CHEMBL128000 8.34 IC50 4.6 Preclinical
CHEMBL64813 8.21 IC50 6.2 Preclinical
CHEMBL60725 8.04 IC50 9.1 Preclinical
CHEMBL291543 8.02 IC50 9.5 Preclinical
Distribution

pChEMBL Value Distribution

93
5.0
61
5.5
74
6.0
39
6.5
38
7.0
11
7.5
10
8.0
4
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

CELECOXIB
CHEMBL118
Approved 1998
DICLOFENAC
CHEMBL139
Approved 1988
PIROXICAM
CHEMBL527
Approved 1982
MECLOFENAMATE SODIUM
CHEMBL1562610
Approved 1980
MECLOFENAMIC ACID
CHEMBL509
Approved 1980
NAPROXEN
CHEMBL154
Approved 1976
IBUPROFEN
CHEMBL521
Approved 1974
INDOMETHACIN
CHEMBL6
Approved 1965
Assay Landscape

Assay Landscape

112
Total Assays
337
Tested Compounds
2
Assay Types
Binding — 92 assays, 337 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 33 234 5.7
protein format 32 48 5.8
assay format 26 54 5.9
tissue-based format 1 1 5.8
Functional — 20 assays, 83 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 9 57 5.3
cell-based format 5 26 7.1
organism-based format 5 0
tissue-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine